TY  - ADVS
AU  - Richardson,Paul G.
TI  - The evolving role of novel and next generation therapies in the management of multiple myeloma: part 2 of 2, relapse refractory multiple myeloma 
T2  - The biomedical & life sciences collection,
PY  - 2019///
CY  - London
PB  - Henry Stewart Talks
KW  - Antibody-drug conjugates
KW  - Antineoplastic agents
KW  - Multiple myeloma
KW  - Chemotherapy
KW  - Treatment
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Bortezomib
KW  - Cancer Vaccines
KW  - Drug Discovery
KW  - elotuzumab.
KW  - Immunoconjugates
KW  - Immunotherapy
KW  - trends
KW  - isatuximab
KW  - Multiple Myeloma
KW  - drug therapy
KW  - immunology
KW  - therapy
KW  - Receptors, Antigen, T-Cell
KW  - Recurrence
KW  - T-Lymphocytes
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: T-cell therapy strategies for Multiple Myeloma -- Cell-based Myeloma vaccines -- Antibody-drug conjugates -- Continuing evolution of Multiple Myeloma treatment; Access restricted to subscribers
UR  - https://hstalks.com/bs/3990/
ER  -